Denosumab and Changes in Bone Turnover Markers During Androgen Deprivation Therapy for Prostate Cancer

Androgen deprivation therapy (ADT) for prostate cancer increases fracture risk, decreases bone mineral density, and increases bone turnover markers (BTMs) including serum type 1 C-telopeptide (sCTX), tartrate-resistant alkaline phosphatase 5b (TRAP-5b), and procollagen-1 N-terminal telopeptide (P1NP...

Full description

Saved in:
Bibliographic Details
Main Authors: Smith, Matthew R, Saad, Fred, Egerdie, Blair, Sieber, Paul, Tammela, Teuvo LJ, Leder, Benjamin Z, Ke, Chunlei, Goessl, Carsten
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3222788/
https://ncbi.nlm.nih.gov/pubmed/21898590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.492
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items